Chilean Soapbark Tree — Hermetica Encyclopedia
Bark · Other

Chilean Soapbark Tree

Strong EvidenceCompound1 PubMed Study

Hermetica Superfood Encyclopedia

The Short Answer

The Chilean Soapbark Tree (Quillaja saponaria) produces QS saponins, particularly QS-21 and QS-7, which are FDA-approved triterpene glycosides used as vaccine adjuvants in shingles, malaria, and COVID-19 vaccines. These compounds enhance immune response through immunostimulant activity involving complex 16-step biosynthetic pathways with cytochrome P450 enzymes and glycosyltransferases.

1
PubMed Studies
5
Validated Benefits
1
Synergy Pairings
At a Glance
CategoryBark
GroupOther
Evidence LevelStrong
Primary Keywordchilean soapbark tree benefits
Synergy Pairings4

Health Benefits

Stimulates the immune system and enhances vaccine efficacy through its saponin content.
Supports respiratory health by acting as an expectorant, traditionally used for coughs and respiratory ailments.
Protects cells from oxidative stress due to its rich content of polyphenols and flavonoids.
Helps reduce cholesterol levels by binding bile acids and enhancing their excretion.
Offers natural cleansing properties, supporting healthy skin and scalp

Origin & History

The Chilean Soapbark Tree (Quillaja saponaria) is native to the temperate forests of central Chile, thriving in dry, rocky soils and semi-arid climates. This evergreen tree is a vital component of Chile's biodiversity, known for its bark's high saponin content. It is increasingly valued in functional nutrition for its immune-modulating and respiratory-supportive properties.

For centuries, the Indigenous Mapuche people of Chile have revered the Soapbark Tree (Quillaja saponaria) as a natural remedy for respiratory health, skin care, and cleansing. It holds significant cultural importance as a symbol of resilience and utility, bridging traditional knowledge with modern sustainable applications.Traditional Medicine

Scientific Research

While traditional uses are well-documented, scientific studies are primarily focused on the isolated saponins from Quillay bark, investigating their immunomodulatory effects and potential as vaccine adjuvants. Further research is needed to fully characterize the broader health benefits of the whole bark.

Preparation & Dosage

Common forms
Dried bark, powder, extracts, tinctures.
Preparation
Dried bark is powdered for teas, tinctures, or topical applications; extracts are used as emulsifiers in beverages and cosmetics.
Dosage
Consult product guidelines or a healthcare provider, as raw bark can be potent.

Nutritional Profile

- Phytochemicals: Saponins, polyphenols, flavonoids. - Vitamins: Vitamin C, Vitamin A.

How It Works

Mechanism of Action

QS-21 and QS-7 saponins contain glycosylated triterpene scaffolds with D-fucose sugar chains and 18-carbon acyl chains that act as immunostimulants. These compounds are biosynthesized through 16 enzymatic steps involving cytochrome P450s (CYP716A224, CYP716A297) for triterpene oxidation to quillaic acid intermediates, and glycosyltransferases (UGT73CY3, UGT73CY2) for sugar chain assembly. The mechanism enhances vaccine potency by boosting host immune responses through molecular pathways involving β-amyrin and oleanolic acid precursors.

Clinical Evidence

QS-21 is clinically proven as an FDA-approved adjuvant in human vaccines including shingles, malaria, and COVID-19 formulations, though specific trial data with participant numbers and efficacy percentages are not detailed in current literature. QS-7 demonstrates proven clinical efficacy in vaccine applications but faces purification challenges from bark extracts. While traditional respiratory and immune uses are well-documented, rigorous clinical trials focusing on whole bark preparations rather than isolated saponins remain limited. Current clinical applications are primarily centered on purified saponin fractions rather than crude bark extracts.

Safety & Interactions

Crude QuilA bark extract exhibits high toxicity and is unsuitable for human use due to safety concerns. Fractionated QS-21 and QS-7 saponins demonstrate reduced toxicity profiles compared to crude extracts, with QS-21 selected for clinical use despite some risks due to its abundance in bark. QS-18 shows high toxicity in animal models and is not used clinically. Specific drug interactions and contraindications are not well-characterized in available research, requiring caution in clinical applications.

Synergy Stack

Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Immune & Inflammation

Also Known As

Quillaja saponariaSoapbark treeQuillajaSoap bark treeChilean soap bark

Frequently Asked Questions

What makes QS-21 from Chilean soapbark effective as a vaccine adjuvant?
QS-21 contains a complex triterpene glycoside structure with D-fucose sugar chains and an 18-carbon acyl chain that are critical for immunostimulant activity. This molecular structure enhances vaccine potency by boosting the host immune response through specific glycosylated pathways.
How are QS saponins extracted and purified from Chilean soapbark?
QS saponins are extracted from the bark through a complex 16-step biosynthetic process involving cytochrome P450 enzymes and glycosyltransferases. QS-21 is more abundant in bark extracts than QS-7, making it easier to purify for clinical applications.
Is crude Chilean soapbark extract safe for human consumption?
No, crude QuilA bark extract exhibits high toxicity and is unsuitable for human use. Only fractionated, purified saponins like QS-21 and QS-7 have reduced toxicity profiles suitable for clinical applications as vaccine adjuvants.
Which vaccines currently use Chilean soapbark saponins?
QS-21 saponins are FDA-approved adjuvants used in shingles, malaria, and COVID-19 vaccines. These purified compounds enhance vaccine efficacy by stimulating stronger immune responses compared to vaccines without adjuvants.
What is the difference between QS-21 and QS-7 saponins?
Both are triterpene glycosides with similar structures, but QS-21 is far more abundant in bark extracts making it easier to obtain commercially. QS-7 has proven clinical efficacy but faces greater purification challenges from natural bark sources.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.